- Home
- VMD vs MTLS Comparison
VMD vs MTLS Comparison
Compare VMD & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VMD | MTLS |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.2M | 317.9M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VMD | MTLS |
|---|---|---|
| Price | $9.94 | $6.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 237.5K | 125.3K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.14 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $270,280,000.00 | N/A |
| Revenue This Year | $17.88 | $6.38 |
| Revenue Next Year | $14.98 | $6.45 |
| P/E Ratio | $163.58 | ★ $61.39 |
| Revenue Growth | ★ 20.52 | N/A |
| 52 Week Low | $5.93 | $4.78 |
| 52 Week High | $10.18 | $6.80 |
Technical Indicators
Market Signals| Indicator | VMD | MTLS |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 72.74 |
| Support Level | $9.22 | $5.38 |
| Resistance Level | $10.04 | $6.80 |
| Average True Range (ATR) | 0.36 | 0.23 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 93.45 | 100.00 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
About MTLS Materialise NV
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.